Formula-fed preterm neonates.

J C Picaud

Home/Archive/PubMed

PubMed · 12900708

Formula-fed preterm neonates.

J C Picaud

View original source ↗Export metadata ↓

Abstract

In very immature babies, nutrition often begined with human milk, but a lot of mothers have a difficulty in lactating and banked human milk is not always available. Therefore, preterm formulas have been specifically designed for very low birth weight (VLBW) infants during hospitalisation stay. They differ significantly from standard term formulas and their derivatives, such as extensively hydrolyzed protein formulas, which are not nutritionally adapted for these infants. Partially hydrolyzed protein formulas have been tried, but infants fed these formulas have a decreased nitrogen intestinal absorption rate. As a result the nitrogen content needs to be increased each time a partially hydrolyzed protein source is used in preterm formulas instead of an entire protein source. Although mineral retention in VLBW infants fed a formula is lower than in utero it might be sufficient. We recently observed an early catch up of bone mineralisation at theoretical term in VLBW infants fed a preterm formula containing highly soluble calcium salts. Probiotics and prebiotics are not yet well evaluated in preterm infants but might help in improving the development of physiologic intestinal flora and enteral feeding tolerance. There is still debate about optimal posthospital nutrition in preterm infants who are not breastfed. Feeding a nutrient-enriched formula provides a growth benefit when compared to infants fed a term formula, mainly during the first 2 to 3 months after discharge. Data about the harmful effects of using such formulas for a longer period are scarce. Therefore, the use of nutrient-enriched formula might be suggested for the first 2 months after discharge, as it is a crucial period in the development of these VLBW infants.

Explore related subjects

Dietary Proteins Energy Intake Fatty Acids, Essential Humans Infant Formula Infant, Newborn Infant, Premature Infant, Small for Gestational Age Intestines Minerals Nutritional Physiological Phenomena Probiotics Vitamin D Journal Article Review

Keep this discovery

Explore connections, maps & timelines

BibTeX RIS

J C Picaud. 2003. Formula-fed preterm neonates.. https://pubmed.ncbi.nlm.nih.gov/12900708/

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

PubMed2003

Proteomics: general strategies and application to nutritionally relevant proteins.

Proteomics as a subset of applied genomics technologies will be a key area of biology during the first decade or two of the new Millennium, and that it will have major impact, both directly and indirectly, on nutritional science. The aim of this review is to summarize information about general strategies of proteome and its application to important food proteins (plant, animal, and microbial). Methods are also described for protein separation, identification and determination. This article covers papers published within the last decade.

Dietary Proteins↗

PubMed2003

Outcome and survival of 88 patients with urea cycle disorders: a retrospective evaluation.

UNLABELLED: This paper presents data obtained by questionnaires sent to local hospitals and metabolic centres in Germany, Austria, Italy and Switzerland concerning the survival and outcome of patients with urea cycle disorders treated between 1975 and 1986. A total of 130 questionnaires were sent out of which 88 questionnaires of patients were returned. This study compares results of conservative long-term management using protein restriction versus protein restriction combined with more extensive treatment (arginine/citrulline, essential amino acid supplements and sodium benzoate as alternate pathway therapy). While survival was improved in neonates receiving extensive therapy, there was an increased risk of mental retardation on long-term follow-up in this group. The time at which the first symptoms of hyperammonaemia appeared, the age at diagnosis, and the time of delay in diagnosis after the first symptom were not helpful in predicting outcome; however, when plasma ammonia concentrations exceeded 300 micromol/l initially or 480 micromol/l at its peak, none of the patients had a normal cognitive outcome. CONCLUSION: there is a need to establish improved treatment approaches and a network of "rare disease" centres to assure the rapid diagnosis and effective treatment and follow-up of affected children. This should precede any consideration of neonatal screening for urea cycle disorders.

Dietary Proteins↗

PubMed2003

Formulas containing hydrolysed protein for prevention of allergy and food intolerance in infants.

BACKGROUND: Allergies and food reactions are common and may be associated with foods including adapted cow's milk formulas. Formulas containing hydrolysed proteins have been used to treat infants with allergy or food intolerance, and have been advocated for prevention of allergy and food intolerance in infants. OBJECTIVES: To determine whether use of hydrolysed formulas for infant feeding prevents allergy and food intolerance. If hydrolysed formulas are effective, to determine what type of hydrolysed formula is most effective including extensively and partially hydrolysed formulas. To determine which infants benefit including infants at low or high risk of allergy and infants receiving early, short term or prolonged formula feeding. SEARCH STRATEGY: The standard search strategy of the Cochrane Neonatal Review Group was used including searches of the Cochrane Controlled Trials Register (2003, Issue 1), MEDLINE (1966 - January 2003), EMBASE (1980 - January 2003) and CINAHL (1982 - January 2003) and previous reviews including cross references. SELECTION CRITERIA: Randomised and quasi-randomised trials that compare the use of a hydrolysed infant formula to human milk or cow's milk formula. Trials with >80% follow up of participants were eligible for inclusion. DATA COLLECTION AND ANALYSIS: Eligibility of studies for inclusion, methodological quality and data extraction were assessed independently by each reviewer. Primary outcomes included clinical allergy, specific allergies and food intolerance. Meta-analysis was conducted using a fixed effects model. MAIN RESULTS: Eighteen trials met criteria for inclusion. No eligible trials compared prolonged hydrolysed formula to human milk feeding. Two trials compared early, short term hydrolysed formula to human milk feeding and reported no significant difference in infant allergy or childhood cow's milk allergy (CMA). Two trials compared early, short term hydrolysed formula to cow's milk formula feeding with no significant benefits reported. One large quasi-random study reported a reduction in infant CMA of borderline significance in low risk infants (RR 0.62, 95% CI 0.38, 1.00).Seven studies compared prolonged feeding of hydrolysed formula to cow's milk formula without using co-interventions for allergy prevention. Meta-analysis of 4 studies (386 infants) found a significant reduction in allergy incidence in infancy (typical RR 0.63, 95% CI 0.47, 0.85; RD -0.15, 95% CI -0.25, -0.06). One study reported a significant reduction in allergy incidence in childhood (RR 0.54, 95% CI 0.36, 0.81). Significant reductions were found in asthma prevalence in childhood, eczema incidence in infancy and prevalence in childhood, food allergy prevalence in childhood, and CMA incidence in infancy. All studies enrolled infants at high risk of allergy. Only three trials comparing prolonged hydrolysed formula feeding to cow's milk formula feeding were considered of good methodology. Only one of these trials demonstrated a benefit into childhood (5 years of age). No eligible trials examined the effects of prolonged hydrolysed formula feeding on allergy beyond early childhood. Costs were not reported. Three trials compared prolonged feeding with an extensive to a partially hydrolysed formula and reported no significant difference in allergy incidence in infancy. REVIEWER'S CONCLUSIONS: There is no evidence to support feeding with a hydrolysed formula for the prevention of allergy in preference to exclusive breast feeding. In high risk infants who are unable to be completely breast fed, there is evidence that prolonged feeding with a hydrolysed compared to a cow's milk formula reduces infant and childhood allergy and infant CMA. Further trials are required to determine if significant clinical benefits persist beyond 5 years of age and if there is any additional benefit from use of an extensive compared to a partially hydrolysed formula. Incremental costs of formula and the effect on compliance should be measured.

Dietary Proteins↗